SNIPR Biome reports positive clinical interim results for groundbreaking, first-in-human, CRISPR-based microbial gene therapy ...Middle East

SNIPR001 demonstrates proof of principle in reducing E. coli levels in the human gastrointestinal tract SNIPR001 is a novel CRISPR-Cas therapeutic, selectively targeting antibiotic-resistant E. coli which can cause life-threatening infections in vulnerable hematological cancer patients...

Hence then, the article about snipr biome reports positive clinical interim results for groundbreaking first in human crispr based microbial gene therapy was published today ( Wednesday 31/05/2023 - 09:48 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( SNIPR Biome reports positive clinical interim results for groundbreaking, first-in-human, CRISPR-based microbial gene therapy )

Also on site :

• UN renews Sudan ceasefire appeal over ‘unimaginable suffering’ of civilians
• Central African Republic election: Who’s running and what’s at stake?
• Israeli forces continue ceasefire violations with attacks across Gaza